| Literature DB >> 18378538 |
Abstract
Extravasation is an unusual but potentially severe complication of vesicant chemotherapy administration. Some extravasation injuries prompt litigation and the oncologist's actions, or lack of action, are scrutinized in the courtroom. This article presents advice and recommendations for treating patients who receive vesicants and includes a discussion of FDA-approved vesicant extravasation treatments and antidotes.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18378538 DOI: 10.1634/theoncologist.2007-0191
Source DB: PubMed Journal: Oncologist ISSN: 1083-7159